Scaling in Vitro Activity of CYP3A7 Suggests Human Fetal Livers Do Not Clear Retinoic Acid Entering from Maternal Circulation

Overview

Journal Sci Rep

Specialty Science

Date 2019 Mar 16

PMID 30874620

Citations 11

Authors

Ariel R Topletz

Guo Zhong

Nina Isoherranen

Affiliations

Soon will be listed here.

Abstract

All-trans-retinoic acid (atRA), the active metabolite of vitamin A, is a critical signaling molecule during embryonic and fetal development and is necessary for maternal health. Fetal exposure to endogenous atRA is tightly regulated during gestation in a tissue specific manner and maternal exposure to exogenous retinoids during pregnancy is teratogenic. The clearance of atRA is primarily mediated by the cytochrome P450 (CYP) 26 enzymes, which play an essential role in controlling retinoid gradients during organogenesis. We hypothesized that CYP26 enzymes in the human fetal liver also function as a protective barrier to prevent maternal atRA reaching fetal circulation. Using human fetal liver tissue, we found that the mRNA of CYP26A1 and CYP26B1 enzymes is expressed in the human fetal liver. However, based on inhibition studies, metabolite profiles and correlation of atRA metabolism with testosterone hydroxylation, clearance of atRA in the fetal livers was mediated by CYP3A7. Based on in vitro-to-in vivo scaling, atRA clearance in the fetal liver was quantitatively minimal, thus providing an insufficient maternal-fetal barrier for atRA exposure.

Citing Articles

Predictive Models for Human Cytochrome P450 3A7 Selective Inhibitors and Substrates.

Xu T, Kabir M, Sakamuru S, Shah P, Padilha E, Ngan D J Chem Inf Model. 2023; 63(3):846-855.

PMID: 36719788 PMC: 10664139. DOI: 10.1021/acs.jcim.2c01516.

Per- and polyfluoroalkyl substances (PFAS) inhibit cytochrome P450 CYP3A7 through direct coordination to the heme iron and water displacement.

Hvizdak M, Kandel S, Work H, Gracey E, McCullough R, Lampe J J Inorg Biochem. 2023; 240:112120.

PMID: 36638633 PMC: 10016736. DOI: 10.1016/j.jinorgbio.2023.112120.

Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.

Balhara A, Kumar A, Unadkat J J Clin Pharmacol. 2022; 62 Suppl 1:S94-S114.

PMID: 36106781 PMC: 9494623. DOI: 10.1002/jcph.2117.

Plasma Retinoid Concentrations Are Altered in Pregnant Women.

Czuba L, Fay E, LaFrance J, Smith C, Shum S, Moreni S Nutrients. 2022; 14(7).

PMID: 35405978 PMC: 9002937. DOI: 10.3390/nu14071365.

Mechanisms of Feedback Regulation of Vitamin A Metabolism.

OConnor C, Varshosaz P, Moise A Nutrients. 2022; 14(6).

PMID: 35334970 PMC: 8950952. DOI: 10.3390/nu14061312.

References

Thatcher J, Buttrick B, Shaffer S, Shimshoni J, Goodlett D, Nelson W . Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase. Mol Pharmacol. 2011; 80(2):228-39. PMC: 3141886. DOI: 10.1124/mol.111.072413. View

Topletz A, Thatcher J, Zelter A, Lutz J, Tay S, Nelson W . Comparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylases. Biochem Pharmacol. 2011; 83(1):149-63. PMC: 3229621. DOI: 10.1016/j.bcp.2011.10.007. View

Topletz A, Tripathy S, Foti R, Shimshoni J, Nelson W, Isoherranen N . Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids. Mol Pharmacol. 2014; 87(3):430-41. PMC: 4352583. DOI: 10.1124/mol.114.096784. View

de Wildt S, Kearns G, Leeder J, van den Anker J . Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet. 2000; 37(6):485-505. DOI: 10.2165/00003088-199937060-00004. View

Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P . A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science. 2007; 315(5813):820-5. DOI: 10.1126/science.1136244. View

Creech Kraft J, Lofberg B, Chahoud I, Bochert G, Nau H . Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice. Toxicol Appl Pharmacol. 1989; 100(1):162-76. DOI: 10.1016/0041-008x(89)90099-9. View

Betts S, Bjorkhem-Bergman L, Rane A, Ekstrom L . Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors. Basic Clin Pharmacol Toxicol. 2015; 117(4):261-6. DOI: 10.1111/bcpt.12392. View

Clagett-Dame M, Knutson D . Vitamin A in reproduction and development. Nutrients. 2012; 3(4):385-428. PMC: 3257687. DOI: 10.3390/nu3040385. View

Ross A, Zolfaghari R . Cytochrome P450s in the regulation of cellular retinoic acid metabolism. Annu Rev Nutr. 2011; 31:65-87. PMC: 3789243. DOI: 10.1146/annurev-nutr-072610-145127. View

10.

Nies A, SHAND D, Wilkinson G . Altered hepatic blood flow and drug disposition. Clin Pharmacokinet. 1976; 1(2):135-55. DOI: 10.2165/00003088-197601020-00005. View

11.

MacLean G, Dolle P, Tahayato A, Chambon P, Petkovich M . Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development. Mech Dev. 2001; 107(1-2):195-201. DOI: 10.1016/s0925-4773(01)00463-4. View

12.

Diaz P, Huang W, Keyari C, Buttrick B, Price L, Guilloteau N . Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase. J Med Chem. 2016; 59(6):2579-95. PMC: 4836378. DOI: 10.1021/acs.jmedchem.5b01780. View

13.

Schiessl B, Fakler U, Vogt M, Friese K, Hess J, Oberhoffer R . 3-Dimensional sonographic volumetry of fetal brain, liver and myocardial mass--interdisciplinary clinical validation of the method and application in fetuses with and without structural heart disease. Z Geburtshilfe Neonatol. 2011; 215(2):60-8. DOI: 10.1055/s-0030-1268431. View

14.

Leeder J, Gaedigk R, Marcucci K, Gaedigk A, Vyhlidal C, Schindel B . Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther. 2005; 314(2):626-35. DOI: 10.1124/jpet.105.086504. View

15.

Nau H . Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid. J Am Acad Dermatol. 2001; 45(5):S183-7. DOI: 10.1067/mjd.2001.113720. View

16.

Abu-Abed S, MacLean G, Fraulob V, Chambon P, Petkovich M, Dolle P . Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis. Mech Dev. 2001; 110(1-2):173-7. DOI: 10.1016/s0925-4773(01)00572-x. View

17.

Xi J, Yang Z . Expression of RALDHs (ALDH1As) and CYP26s in human tissues and during the neural differentiation of P19 embryonal carcinoma stem cell. Gene Expr Patterns. 2008; 8(6):438-442. DOI: 10.1016/j.gep.2008.04.003. View

18.

Gielchinsky Y, Zvanca M, Minekawa R, Persico N, Nicolaides K . Liver volume in trisomy 21 and euploid fetuses at 11 to 13 weeks. Prenat Diagn. 2010; 31(1):28-32. DOI: 10.1002/pd.2633. View

19.

Sutton M, Theard M, Bhatia S, Plappert T, Saltzman D, Doubilet P . Changes in placental blood flow in the normal human fetus with gestational age. Pediatr Res. 1990; 28(4):383-7. DOI: 10.1203/00006450-199010000-00016. View

20.

Chen H, Fantel A, Juchau M . Catalysis of the 4-hydroxylation of retinoic acids by cyp3a7 in human fetal hepatic tissues. Drug Metab Dispos. 2000; 28(9):1051-7. View